SCHEMBL28407396

SCHEMBL28407396

O=C(O)[C@H](O)Cn1cccc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OR51E2 Q9H255 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
TBXAS1 P24557 2/20 0.36
TET2 Q6N021 6/20 0.36
KDM4A O75164 2/20 0.36
KDM4C Q9H3R0 2/20 0.36
KDM2A Q9Y2K7 2/20 0.36
TET3 O43151 2/20 0.36
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TET1 Q8NFU7 1/20 0.33
PTPRA P18433 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMO O15229 1/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
GPR84 Q9NQS5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28407399 1.00 OR51E2 (0.40) OR51E2SMN1; SMN2TBXAS1TET2KDM4A
SCHEMBL25661035 0.74 CYP1A2 (0.43) TBXAS1NPSR1HSD17B10ALDH1A1KMO
SCHEMBL5301611 0.74 KDM4E (0.51) HSD17B10ALDH1A1
SCHEMBL28401270 0.74 ALDH1A1 (0.39) SMN1; SMN2ALDH1A1HDAC1HDAC6
SCHEMBL29586073 0.74 ALDH1A1 (0.39) SMN1; SMN2ALDH1A1HDAC1HDAC6
SCHEMBL23118121 0.73 TBXAS1 (0.61) TBXAS1ALDH1A1
SCHEMBL20514410 0.73 TSHR (0.54) OR51E2TBXAS1KDM4CPTPRAKMO
SCHEMBL20514412 0.73 TSHR (0.54) OR51E2TBXAS1KDM4CPTPRAKMO
SCHEMBL20708981 0.73 TSHR (0.54) OR51E2TBXAS1KDM4CPTPRAKMO
SCHEMBL4652073 0.73 TBXAS1 (0.61) TBXAS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111187277-B Thienopyrimidine derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-04-12 CN disclosed
CN-111187277-A Thienopyrimidine derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2020-05-22 CN disclosed